
Apple Shines, Pres. Trump-Nvidia CEO Meeting, Vertex CEO on Non-Opioid Painkiller Approval 1/31/25
Squawk on the Street
00:00
Breaking New Ground: Gernavix and the Future of Pain Management
This chapter explores the FDA approval of Vertex's groundbreaking painkiller, Gernavix, marking a significant shift in pain management with its non-opioid formulation. It discusses the implications of introducing a new class of pain medication amidst the opioid crisis, while addressing challenges related to effectiveness and cost. The chapter also links the need for safer alternatives to broader public policy discussions on addiction and chronic pain treatment.
Transcript
Play full episode